1. Home
  2. TRUP vs IDYA Comparison

TRUP vs IDYA Comparison

Compare TRUP & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRUP
  • IDYA
  • Stock Information
  • Founded
  • TRUP 2000
  • IDYA 2015
  • Country
  • TRUP United States
  • IDYA United States
  • Employees
  • TRUP N/A
  • IDYA N/A
  • Industry
  • TRUP Medical Specialities
  • IDYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRUP Health Care
  • IDYA Health Care
  • Exchange
  • TRUP Nasdaq
  • IDYA Nasdaq
  • Market Cap
  • TRUP 2.1B
  • IDYA 1.9B
  • IPO Year
  • TRUP 2014
  • IDYA 2019
  • Fundamental
  • Price
  • TRUP $50.81
  • IDYA $22.58
  • Analyst Decision
  • TRUP Buy
  • IDYA Buy
  • Analyst Count
  • TRUP 6
  • IDYA 12
  • Target Price
  • TRUP $53.80
  • IDYA $50.82
  • AVG Volume (30 Days)
  • TRUP 572.9K
  • IDYA 980.1K
  • Earning Date
  • TRUP 08-07-2025
  • IDYA 08-05-2025
  • Dividend Yield
  • TRUP N/A
  • IDYA N/A
  • EPS Growth
  • TRUP N/A
  • IDYA N/A
  • EPS
  • TRUP N/A
  • IDYA N/A
  • Revenue
  • TRUP $1,321,538,000.00
  • IDYA $7,000,000.00
  • Revenue This Year
  • TRUP $11.30
  • IDYA $101.20
  • Revenue Next Year
  • TRUP $6.01
  • IDYA $286.70
  • P/E Ratio
  • TRUP N/A
  • IDYA N/A
  • Revenue Growth
  • TRUP 14.08
  • IDYA N/A
  • 52 Week Low
  • TRUP $29.70
  • IDYA $13.45
  • 52 Week High
  • TRUP $57.90
  • IDYA $44.42
  • Technical
  • Relative Strength Index (RSI)
  • TRUP 44.88
  • IDYA 58.40
  • Support Level
  • TRUP $48.81
  • IDYA $20.99
  • Resistance Level
  • TRUP $53.61
  • IDYA $23.06
  • Average True Range (ATR)
  • TRUP 2.11
  • IDYA 0.94
  • MACD
  • TRUP -0.90
  • IDYA 0.01
  • Stochastic Oscillator
  • TRUP 15.43
  • IDYA 81.25

About TRUP Trupanion Inc.

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue primarily from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: